| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |